Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2022

Open Access 01.12.2022 | Case report

Successful removal of the largest reported intrathoracic lipoma with bilateral extension: a case report

verfasst von: S. M. Tajdit Rahman, Md. Faizul Islam, S. M. Zakirullah Rasha, Abdur Rahim, Tania Binte Ghani Elora, A. K. M. Razzaque

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Unlike subcutaneous lipomas, thoracic cavity lipomas are extremely rare and can develop to be quite large without causing any symptoms. However, managing massive lipoma that involves both chest cavities is usually challenging, especially when considering the approach for excision.

Case

We report our experience of surgical management of a case of a 46-year-old male with huge intrathoracic lipoma that extends bilaterally and is known to be the largest of such kind. The tumor was resected successfully using median sternotomy. Histological analysis confirmed features of lipoma.

Conclusion

To remove a bilateral intrathoracic lipoma, various surgical approaches have been documented. In our experience, a median sternotomy allows better exposure, which aids in complete surgical extirpation resulting in the prevention of recurrence.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CXR
Chest X-ray
CECT
Contrast enhanced computed tomography
CT
Computed tomography
FNAC
Fine needle aspiration cytology
FVC
Forced vital capacity
FEV1
Forced expiratory volume in first second
MRI
Magnetic resonance imaging
VATS
Video-assisted thoracoscopic surgery

Introduction

Lipomas are the most prevalent benign mesenchymal tumors, while intrathoracic lipoma is a rare entity. On the other hand, giant lipoma involving both hemithorax is far more unusual, with only a few occurrences documented in the literature [13]. Lipomas in the intrathoracic region often go unnoticed, especially if they are small. Despite the fact that a giant lipoma in the chest cavity might cause symptoms, it is frequently identified during a routine medical evaluation [2, 4].
Surgical removal is still the primary line treatment for intrathoracic tumors with a good outcome [1, 2]. However, managing massive lipoma that involves both chest cavities is usually challenging, when considering the approach.
Here, we present our experience of surgical management of a case of a 46-year-old male with huge intrathoracic lipoma that extends bilaterally, displacing the lung upwards. To our knowledge, this is the largest reported intrathoracic lipoma with the bilateral extension, which was removed successfully through standard median sternotomy.

Case presentation

A 46-year-old hypertensive man presented to our outpatient clinic with a dry cough that had been bothering him for 3 weeks, as well as periodic shortness of breath with chest heaviness when exerted. He has no prior history of chest pain, hemoptysis, or weight loss, nor does he have any relevant medical history. His blood pressure is controlled with medication. He was a cook, non-alcoholic, non-smoker, and having a body weight of 65 kg for his 166 cm height.
Physical examination of the patient revealed absent breath sounds along with dullness on percussion over both the middle and lower chest. Routine blood workup was within the standard limit except for mild anemia and raised ESR.
A routine chest X-ray revealed a massive homogenous mass that occupied the lower two-thirds of both chests (Fig. 1a). CECT revealed a substantial fat density area (24 cm transverse, 16 cm cranio-caudal, 17 cm AP dimension) at the mid and lower parts of both chests, involving the mediastinal fat plane compressing and shifting both lungs upwards (Fig. 2). A CT-guided FNAC was performed, and the smear showed polymorph, lymphocytes, and fatty tissue fragments on a blood background, indicating lipoma. Spirometry revealed an obstructive pattern with a forced expiratory volume in first second (FEV1) of 1.2 L (42% predicted), forced vital capacity (FVC) 1.7 L (49% predicted) and FEV1/FVC ratio of 70%. Preoperative echocardiography showed no evidence of cardiac compression with an ejection fraction of 61%.
The chest cavity was explored through a standard median sternotomy to provide complete access to both the pleural cavities and the mediastinum in order to remove the massive intrathoracic lipoma. The gross appearance was a thinly encapsulated, lobulated, dull mass with a pale yellow color that had a smooth surface and was soft to the touch (Fig. 3). Mass was continuous with the fat plane of the anterior mediastinum and supra cardiac blood vessel. The right-sided part of the mass was much larger than the left side. There were few adhesions with both lungs, and the lungs were compressed by the tumor. By blunt and sharp dissection and manipulation, tumor from both chest cavity and mediastinum were completely separated and removed. We did not find any obvious vascular pedicle for the tumor during mobilisation except few tiny vessels from mediastinum.
The resected tumor weighed around 5400 g. It contains four lobulated parts, the largest of which is approximately 24*10*8 cm in size. The cut section comprises yellow lobulated fatty tissue (Fig. 4). Final histologic analysis of the tumor revealed an encapsulated tumor with abundant mature adipose tissue, a few scattered strands of fibroconnective tissue,  and multiple foci of fat necrosis (Fig. 5). There was no evidence of abnormal mitosis or invasive cancer.
The postoperative period went smoothly, and on the sixth postoperative day, the patient was discharged home after removing the chest and mediastinal drain with a normal chest X-ray. His physical capacity and respiratory health both improved considerably after he was discharged. After 1 month of removal of the mass, we performed a spirometry to see the improvement of lung function. We observed FVC improved to 2.6 L form 1.7 L and FEV1 improved to 2.0 L from preoperative 1.2 L.
At 6 months of follow-up, there was no evidence of recurrence, and the CXR was normal (Fig. 1b).

Discussion

Lipomas are benign tumors of adipose tissue and the most common benign tumor in adults, accounting for 20% of all benign soft-tissue tumors. Lipoma is primarily made up of immature fat cells, although it can also contain mesodermal components other than adipocytes, such as varying quantities of fibrous tissues and blood vessels [5]. lipomas within the thoracic cavity are extremely uncommon, which was first described by Fothergil [6]. It can be found in mediastinal, diaphragmatic, bronchial, and pulmonary levels [7].
Most people with intrathoracic lipomas are asymptomatic; nevertheless, because lipomas can grow to enormous sizes, they can cause pressure effects, which vary according to the location and size of the lipomas. Symptoms such as dyspnoea and dysphagia might be caused by local compression on neighboring structures such as the trachea or esophagus [7, 8]. Certain authors have even suggested that the mediastinal structure can be compressed by giant intrathoracic lipoma [9, 10]. They can also cause various problems like chest pain and fever, as well as invading intercostal spaces and causing rib lysis [11, 12]. In our case, the patient’s shortness of breath was due to the compressed lung by the massive size of the lipoma, resulting from reduced lung volume. We did not find any intrathoracic lipoma in the literature more than 3500 gm and as large as the reported case by us [1, 13].
Although intrathoracic lipoma is usually detected incidentally in a chest X-ray, a homogeneous fat attenuation mass (50–150 HU) that creates obtuse angles with the chest wall and displaces neighboring pulmonary parenchyma and arteries on a chest CT permits a conclusive diagnosis [1, 2, 5, 11]. Additionally, magnetic resonance imaging (MRI), particularly with fat saturation, is supportive in determining the lipomatous nature of the tumor. Furthermore, MRI helps to distinguish between lipomas and well-differentiated liposarcomas based on margins, signal homogeneity, and septa or nodules [14, 15]. Preoperative percutaneous biopsy and FNAC may not always show the presence of malignant cells due to inadequate sample and cannot completely able to exclude the presence of sarcoma.
When possible, total en-bloc excision of lipoma is the definitive treatment choice for preventing future recurrences. Complete surgical excision using the lateral thoracotomy or standard median sternotomy is the most applied surgical approach for intrathoracic lipoma [16]. Clamshell thoracotomy has also been employed to remove the bilateral intrathoracic lipoma [17]. Whereas, median sternotomy allows complete assessment of both chest cavities and the mediastinum, which ensures en-bloc removal of the encapsulated tumor [13]. In our experience, lateral thoracotomy may affect the exposure in case of a large tumor, resulting in rupture of the capsule [2]. We believe exposure is the main key to ensure en-bloc resection and choosing surgical exposure. In our previous case we did piecemeal excision of the mass through lateral thoracotomy which caused prolong intrathoracic drain. Though clamshell thoracotomy was mentioned in different articles for bilateral intrathoracic tumor, we avoided it due to our concern of upper limit of the tumor and previous disastrous postoperative experiences related to this particular approach. In the literature, video-assisted thoracoscopic surgery (VATS) has been suggested as a technique for thoracic tumors that are usually pedunculated, tiny in size, and do not have infiltrating growth [5].
Intraoperative problems are not infrequent because of severe adhesions with important structures caused by the mass's chronic existence in the thoracic cavity, as in our instance, where it was firmly connected to the innominate vein and superior venacva. Local recurrence of intrathoracic or mediastinal lipomas after resection is infrequent. They may, however, recur locally, and the risk of recurrence following an excision has been documented in the literature to be less than 5% [18]. Despite the fact that intrathoracic lipomas are histologically benign, close monitoring and follow-up are required to identify any recurrence.

Conclusion

Intrathoracic lipomas are rare benign tumor in contrast of subcutaneous lipoma which is very common. They typically grow very slowly over years without any symptoms and signs. They often found in routine investigations incidentally when they become large. Whereas CT and MRI are usually diagnostic. Although pleural lipoma never evolves towards liposarcoma, surgical resection is still necessary and must be resected completely to prevent further recurrence.

Acknowledgements

We would like to thank the patient who kindly gave consent for the case to be presented in this manuscript. We also send our vote of the thanks to the entire Department of Thoracic Surgery, National Institute of Diseases of the Chest and Hospital, Dhaka, Bangladesh and Thoracic and Upper GI Surgery Centre, Green Life Hospital, Dhaka.

Declarations

Written informed consent was taken from the patient for publication of this case report and accompanying images. A copy of the written consent is available with the report.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Beshay M, Schmid RA. Intrathoracic giant lipoma. Ann Thorac Surg. 2004;78:1850.CrossRef Beshay M, Schmid RA. Intrathoracic giant lipoma. Ann Thorac Surg. 2004;78:1850.CrossRef
4.
Zurück zum Zitat Politis J, Funahashi A, Gehlsen JA, DeCock D, Stengel BF, Choi H. Intrathoracic lipomas. Report of three cases and review of the literature with emphasis on endobronchial lipoma. J Thorac Cardiovasc Surg. 1979;77:550–6.CrossRef Politis J, Funahashi A, Gehlsen JA, DeCock D, Stengel BF, Choi H. Intrathoracic lipomas. Report of three cases and review of the literature with emphasis on endobronchial lipoma. J Thorac Cardiovasc Surg. 1979;77:550–6.CrossRef
5.
Zurück zum Zitat Kamata S, Ishida I, Suzuki Y, Yamada T, Yaegashi H, Oura H. Intrathoracic fibrolipoma resected using complete thoracoscopic surgery: a case report. J Cardiothorac Surg. 2018;13(1):112.CrossRef Kamata S, Ishida I, Suzuki Y, Yamada T, Yaegashi H, Oura H. Intrathoracic fibrolipoma resected using complete thoracoscopic surgery: a case report. J Cardiothorac Surg. 2018;13(1):112.CrossRef
6.
Zurück zum Zitat Fothergill J. Lipoma of the external thoracic wall. Eur Respir J. 1994;7:207–9. Fothergill J. Lipoma of the external thoracic wall. Eur Respir J. 1994;7:207–9.
7.
Zurück zum Zitat Chen, et al. Intrathoracic giant pleural lipoma: case report and review of the literature. J Cardiothorac Surg. 2015;8:1966. Chen, et al. Intrathoracic giant pleural lipoma: case report and review of the literature. J Cardiothorac Surg. 2015;8:1966.
8.
Zurück zum Zitat Cutilli T, Schietoma M, Marcelli VA, Ascani G, Corbacelli A. Giant cervico-mediastinal lipoma. A clinical case. Minerva Stomatol. 1999;48:23–8.PubMed Cutilli T, Schietoma M, Marcelli VA, Ascani G, Corbacelli A. Giant cervico-mediastinal lipoma. A clinical case. Minerva Stomatol. 1999;48:23–8.PubMed
9.
Zurück zum Zitat Botianu PV, Cerghizan AM, Botianu AM. Giant right intrathoracic myxoid fusocellular lipoma. Case Rep Pulmonol. 2015;2015:302189.PubMedPubMedCentral Botianu PV, Cerghizan AM, Botianu AM. Giant right intrathoracic myxoid fusocellular lipoma. Case Rep Pulmonol. 2015;2015:302189.PubMedPubMedCentral
10.
Zurück zum Zitat Jack AI, Blohm ME, Lye M. An intrathoracic lipoma impairing left ventricular function. Br Heart J. 1995;74(7):95.CrossRef Jack AI, Blohm ME, Lye M. An intrathoracic lipoma impairing left ventricular function. Br Heart J. 1995;74(7):95.CrossRef
11.
Zurück zum Zitat Andreu C, Yat-Wah P, Fraga J, Olivera MJ, Caballero P. Necrotic lipoma of the posterior mediastinum. Arch Bronconeumol. 2008;44(11):641–4.CrossRef Andreu C, Yat-Wah P, Fraga J, Olivera MJ, Caballero P. Necrotic lipoma of the posterior mediastinum. Arch Bronconeumol. 2008;44(11):641–4.CrossRef
12.
Zurück zum Zitat Buxton RC, Tan CS, Khane NM, Cuasay NS, Shor MJ, Spigos DG. Atypical transmural thoracic lipoma–CT diagnosis. J Comput Assist Tomogr. 1998;12:196–8.CrossRef Buxton RC, Tan CS, Khane NM, Cuasay NS, Shor MJ, Spigos DG. Atypical transmural thoracic lipoma–CT diagnosis. J Comput Assist Tomogr. 1998;12:196–8.CrossRef
14.
Zurück zum Zitat Brisson M, Kashima T, Delaney D, Tirabosco R, Clarke A, Cro S, et al. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification. Skelet Radiol. 2013;42(5):635–47.CrossRef Brisson M, Kashima T, Delaney D, Tirabosco R, Clarke A, Cro S, et al. MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification. Skelet Radiol. 2013;42(5):635–47.CrossRef
15.
Zurück zum Zitat Weiss SW, Goldblum JR. Benign lipomatous tumors and liposarcoma. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss’s soft tissue tumors. 4th ed. St. Louis: Mosby; 2001. p. 571–693. Weiss SW, Goldblum JR. Benign lipomatous tumors and liposarcoma. In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss’s soft tissue tumors. 4th ed. St. Louis: Mosby; 2001. p. 571–693.
16.
Zurück zum Zitat Marulli G, Rea F, Feltracco P, et al. Successful resection of a giant primary liposarcoma of the posterior mediastinum. J Thorac Oncol. 2007;2:453–5.CrossRef Marulli G, Rea F, Feltracco P, et al. Successful resection of a giant primary liposarcoma of the posterior mediastinum. J Thorac Oncol. 2007;2:453–5.CrossRef
18.
Zurück zum Zitat Sakurai H, Kaji M, Yamazaki K, K. Suemasu Intrathoracic lipomas: their clinicopathological behaviors are not as straightforward as expected. Ann Thorac Surg. 2008;86(1):261–5.CrossRef Sakurai H, Kaji M, Yamazaki K, K. Suemasu Intrathoracic lipomas: their clinicopathological behaviors are not as straightforward as expected. Ann Thorac Surg. 2008;86(1):261–5.CrossRef
Metadaten
Titel
Successful removal of the largest reported intrathoracic lipoma with bilateral extension: a case report
verfasst von
S. M. Tajdit Rahman
Md. Faizul Islam
S. M. Zakirullah Rasha
Abdur Rahim
Tania Binte Ghani Elora
A. K. M. Razzaque
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2022
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-022-01954-z

Weitere Artikel der Ausgabe 1/2022

Journal of Cardiothoracic Surgery 1/2022 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.